Advertisement
Screener

RHYTHM PHARMACEUTICALS, INC. (RYTM) Auditor

RHYTHM PHARMACEUTICALS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-26: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2025-02-28: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2024-02-29: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2023-03-01: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-262025-12-31Ernst & Young LLP42Boston, MassachusettsYes
2025-02-282024-12-31Ernst & Young LLP42Boston, MassachusettsYes
2024-02-292023-12-31Ernst & Young LLP42Boston, MassachusettsYes
2023-03-012022-12-31Ernst & Young LLP42Boston, MassachusettsNo
2022-03-012021-12-31Ernst & Young LLP42Boston, MassachusettsYes
2021-03-012020-12-31Ernst & Young LLPBoston, MassachusettsYes
2020-03-022019-12-31Ernst & Young LLPBoston, Massachusetts
2019-03-082018-12-31Ernst & Young LLPBoston, Massachusetts
2018-03-122017-12-31Ernst & Young LLPBoston, Massachusetts

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alkermes plc. (ALKS)$6.844B132.74
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60